OncomineWorld Presentation On-Demand:

Clinical impact of frontline NGS testing in patients with suspected myeloid malignancies

 

 

Presenter

bekim-headshot

 

Bekim Sadikovic, PhD, DABMG, FACMG
Professor, Research Chair, and Program Head, Western University and London Health Sciences, Ontario, Canada

Dr. Sadikovic is Program Head of the Molecular Diagnostics Program, Pathology and Laboratory Medicine - a joint venture between LHSC and St. Joseph's Health Care, London, servicing a wide range of constitutional and oncology molecular genetic diagnostics including Clinical Molecular Genetics, Molecular Pathology, Clinical Cytogenetics, and Biochemical Genetics Laboratories.

His research interests involve application of genomics technologies to clinical diagnostics with particular focus on development of genomic and epigenomic biomarkers in hereditary and acquired genomic conditions. He also serves as the Clinical and Scientific Director of the Verspeeten Clinical Genome Centre, and translational genomics facility which focuses on development and clinical implementation of genomic technologies and biomarkers in care of patients with genomic disorders including hereditary genetic conditions and cancer. The Centre utilizes advanced bioinformatic approaches including machine learning on patient’s clinical and genomics data to novel develop diagnostic tool and technologies.

Have any questions?

Click the button below to speak with a Thermo Fisher Scientific representative.

button_request-contact

 

For Research Use only. Not for use in diagnostic procedures.